Exorenal develops artificial kidney and dialysis machines that utilize advanced filtration technologies to efficiently remove toxins and excess fluids from patients with kidney failure. Their devices provide reliable renal replacement therapy, improving patient outcomes in chronic kidney disease management.
Funding
$5.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with kidney failure often face limitations due to the size and complexity of traditional hemodialysis machines, restricting their access to treatment and impacting their quality of life. Existing portable dialysis solutions may not offer the same performance as stationary devices found in hospitals and clinics.
Solution
Exorenal is developing a compact hemodialysis system designed to provide effective renal replacement therapy in a portable format. The xKidney, their lead product, is a small and lightweight HD device that aims to match the performance of industry-standard stationary machines through advanced APB Technology. Paired with the XRO, a portable reverse osmosis machine, the system delivers dialysate-quality water from tap-to-treatment, increasing accessibility to hemodialysis in various settings. Exorenal's goal is to empower patients with greater freedom and convenience in managing their kidney disease.
Target Audience
The primary target audience includes patients with kidney failure requiring hemodialysis, as well as healthcare providers and clinics seeking more accessible and portable dialysis solutions.
Features
- xKidney: A compact hemodialysis device utilizing APB Technology for efficient toxin and fluid removal.
- XRO: A portable reverse osmosis machine providing dialysate-quality water from tap-to-treatment.
- Intended to match the balancing accuracy and performance of industry-leading stationary hemodialysis machines.
- Designed for ease of setup, operation, and maintenance for both patients and providers.